ADMA BIOLOGICS INC (ADMA) Stock Income Statement
NASDAQ:ADMA - Nasdaq - US0008991046 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 459.38M | 426.45M | 258.21M | 154.10M | 80.90M | |||
| Cost Of Goods | 217.84M | 206.90M | 167.17M | 118.80M | 79.80M | |||
| Gross Profit | 241.54M | 219.55M | 91.04M | 35.30M | 1.20M | |||
| Operating Expenses | 89.50M | 80.57M | 66.64M | 74.60M | 59.50M | |||
| Research and Development | 2.19M | 1.81M | 3.30M | 3.60M | 3.60M | |||
| Selling, General, and Administrative Expenses | 87.09M | 78.37M | 62.62M | 70.30M | 55.20M | |||
| Operating Income | 152.04M | 138.98M | 24.40M | -39.30M | -58.40M | |||
| Interest Income/Expense | -9.81M | -11.83M | -23.41M | -19.20M | -13.00M | |||
| Other Income/Expense | -222.00K | -193.00K | -287.00K | -600.00K | -300.00K | |||
| Non Recurring Items | N/A | -1.24M | -28.94M | -6.70M | 0.00 | |||
| Income Before Taxes | 140.76M | 125.71M | -28.24M | -65.90M | -71.60M | |||
| Income Tax | -66.01M | -71.96M | N/A | N/A | N/A | |||
| Net Income | 206.77M | 197.67M | -28.24M | -65.90M | -71.60M | |||
| EBITDA | 159.94M | 147.03M | 32.73M | -32.19M | -52.90M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.84 | 0.81 | -0.13 | -0.33 | -0.51 | |||
| Non GAAP EPS | 0.53 | 0.50 | -0.13 | -0.31 | -0.52 | |||
| Statistics | ||||||||
| Gross Profit Margin | 52.58% | 51.48% | 35.26% | 22.91% | 1.48% | |||
| Profit Margin | 45.01% | 46.35% | -10.94% | -42.76% | -88.50% | |||
| Operating Profit Margin | 33.10% | 32.59% | 9.45% | -25.50% | -72.19% | |||
All data in USD